| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |